According to the organisers, Bhagwat has agreed to depart from his usual speech format and instead take part in a moderated interaction where young participants are expected to ask questions on ...
ClearPoint Neuro's Q2 miss and preclinical delays weigh on 2026, but regulatory clarity boosts 2027-28 upside. Click to see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results